In Vivo Tracking and 3D Mapping of Cell Death in Regeneration and Cancer Using Trypan Blue

Author:

Procel Nicole1ORCID,Camacho Karen1,Verboven Elisabeth23,Baroja Isabel14,Guerrero Priscila A.1ORCID,Hillen Hanne3ORCID,Estrella-García Carlos1ORCID,Vizcaíno-Rodríguez Nicole1ORCID,Sansores-Garcia Leticia3ORCID,Santamaría-Naranjo Ana5,Romero-Carvajal Andrés6ORCID,Caicedo Andrés7ORCID,Halder Georg3ORCID,Moya Iván M.1

Affiliation:

1. Cancer Research Group, Faculty of Engineering and Applied Sciences, Universidad de Las Américas, Quito 170124, Ecuador

2. Department of Cell and Molecular Biology, Karolinska Institutet, 17165 Stockholm, Sweden

3. VIB Center for Cancer Biology and KU Leuven Department of Oncology, KU Leuven, 3000 Leuven, Belgium

4. Faculty of Health Sciences and Medicine, Universidad de Extremadura, 06800 Mérida, Spain

5. Laboratorios Multidisciplinarios de Ciencias Biológicas y Químicas, Universidad de Las Américas, Quito 170513, Ecuador

6. Escuela de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Quito 170525, Ecuador

7. Colegio de Ciencias de la Salud, Escuela de Medicina, Universidad San Francisco de Quito USFQ, Quito 170901, Ecuador

Abstract

Tracking cell death in vivo can enable a better understanding of the biological mechanisms underlying tissue homeostasis and disease. Unfortunately, existing cell death labeling methods lack compatibility with in vivo applications or suffer from low sensitivity, poor tissue penetration, and limited temporal resolution. Here, we fluorescently labeled dead cells in vivo with Trypan Blue (TBlue) to detect single scattered dead cells or to generate whole-mount three-dimensional maps of large areas of necrotic tissue during organ regeneration. TBlue effectively marked different types of cell death, including necrosis induced by CCl4 intoxication in the liver, necrosis caused by ischemia-reperfusion in the skin, and apoptosis triggered by BAX overexpression in hepatocytes. Moreover, due to its short circulating lifespan in blood, TBlue labeling allowed in vivo “pulse and chase” tracking of two temporally spaced populations of dying hepatocytes in regenerating mouse livers. Additionally, upon treatment with cisplatin, TBlue labeled dead cancer cells in livers with cholangiocarcinoma and dead thymocytes due to chemotherapy-induced toxicity, showcasing its utility in assessing anticancer therapies in preclinical models. Thus, TBlue is a sensitive and selective cell death marker for in vivo applications, facilitating the understanding of the fundamental role of cell death in normal biological processes and its implications in disease.

Funder

Research Foundation Flanders

Universidad de Las Américas

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3